The role of iron in retinal diseases

Studies on Retinal and Choroidal Disorders

Volumn , Issue , 2012, Pages 259-275

  Mehta, Sonia ^a   Dunaief, Joshua L ^b  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84951819055     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-61779-606-7_12     Document Type: Chapter

References (84)

1. Wigglesworth JM, Baum H (1988) Iron-dependent enzymes in the brain. In: Youdim MBH (ed) Topics in neurochemistry and neuropharmacology. Taylor & Francis, London, pp 25-66.
2. Poss KD, Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94:10919-10924.
3. LeVine SM, Macklin WB (1990) Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J Neurosci Res 26:508-512.
4. Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA (1992) Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 144:235-257.
5. Youdim MBH (1990) Neuropharmacological and neurobiochemical aspects of iron deficiency. In: Dobbing J (ed) Brain, behavior, and iron in the infant diet. Springer, London, pp 83-106.
6. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J (1987) Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? Am J Roentgenol (AJR) 149:357-363.
7. Roncagliolo M, Garrido M, Walter T, Peirano P, Lozoff B (1998) Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. Am J Clin Nutr 68:683-690.
8. Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX (2005) RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci USA 102:12413-12418.
9. Schichi H (1969) Microsomal electron transport system of bovine retinal pigment epithelium. Exp Eye Res 8:60-68.
10. Halliwell B, Gutteridge JM (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1-14.
11. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866-9868.
12. Baker E, Morgan EH (1994) Iron transport. In: Brock J, Halliday JH, Pippard MH, Powell LW (eds) Iron metabolism in health and disease. W.B. Saunders, Philadelphia, pp 63-95.
13. Sipe DM, Murphy RF (1991) Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH. J Biol Chem 266:8002-8007.
14. Aisen P, Enns C, Wessling-Resnick M (2001) Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 33:940-959.
15. Hunt RC, Davis AA (1992) Release of iron by human retinal pigment epithelial cells. J Cell Physiol 152:102-110.
16. Dautry-Varsat A, Ciechanover A, Lodish HF (1983) pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 80:2258-2262.
17. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:776-781.
18. Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906-19912.
19. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal ironregulatedtransporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299-309.
20. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, Anderson GJ (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the Sla mouse. Nat Genet 21:195-199.
21. Hentze MW, Kuhn LC (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175-8182.
22. Rouault TA (2002) Post-transcriptional regulation of human iron metabolism by iron regulatory proteins. Blood Cells Mol Dis 29:309-314.
23. Yefimova MG, Jeanny JC, Guillonneau X, Keller N, Nguyen-Legros J, Sergeant C, Guillou F, Courtois Y (2000) Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest Ophthalmol Vis Sci 41:2343-2351.
24. Tripathi RC, Millard CB, Tripathi BJ, Chailertborisuth NS, Neely KA, Ernest JT (1990) Aqueous humor of cat contains fibroblast growth factor and transferrin similar to those in man. Exp Eye Res 50:109-112.
25. Yu TC, Okamura R (1988) Quantitative study of characteristic aqueous humor transferrin, serum transferrin and desialized serum transferrin in aqueous humor. Jpn J Ophthalmol 32:268-274.
26. Hawkins KN (1986) Contribution of plasma proteins to the vitreous of the rat. Curr Eye Res 5:655-663.
27. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482-488.
28. Rouault TA, Cooperman S (2006) Brain iron metabolism. Semin Pediatr Neurol 13:142-148.
29. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66:1198-1207.
30. Burdo JR, Martin J, Menzies SL, Dolan KG, Romano MA, Fletcher RJ, Garrick MD, Garrick LM, Connor JR (1999) Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93:1189-1196.
31. Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE III, Papadopoulos V, Snyder SH (2006) NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51:431-440.
32. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, Drysdale J (2001) A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276:24437-24440.
33. Hahn P, Dentchev T, Qian Y, Rouault T, Harris ZL, Dunaief JL (2004) Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol Vis 10:598-607.
34. Osaki S (1966) Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin). J Biol Chem 241:5053-5059.
35. Chen L, Dentchev T, Wong R, Hahn P, Wen R, Bennett J, Dunaief JL (2003) Increased expression of ceruloplasmin in the retina following photic injury. Mol Vis 9:151-158.
36. Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL (2004) Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 101:13850-13855.
37. Levin LA, Geszvain KM (1998) Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest Ophthalmol Vis Sci 39:157-163.
38. Miyahara T, Kikuchi T, Akimoto M, Kurokawa T, Shibuki H, Yoshimura N (2003) Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey. Invest Ophthalmol Vis Sci 44:4347-4356.
39. Farkas RH, Chowers I, Hackam AS, Kageyama M, Nickells RW, Otteson DC, Duh EJ, Wang C, Valenta DF, Gunatilaka TL, Pease ME, Quigley HA, Zack DJ (2004) Increased expression of iron-regulating genes in monkey and human glaucoma. Invest Ophthalmol Vis Sci 45:1410-1417.
40. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P (2005) Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest Ophthalmol Vis Sci 46:349-357.
41. Li D, Ma W, Sun F, Pavlidis P, Spector A (2004) Cluster analysis of genes with significant change in expression in cells conditioned to survive TBOOH. Exp Eye Res 78:301-308.
42. Sarkar J, Seshadri V, Tripoulas NA, Ketterer ME, Fox PL (2003) Role of ceruloplasmin in macrophage iron efflux during hypoxia. J Biol Chem 278:44018-44024.
43. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 102:1324-1328.
44. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093.
45. Hadziahmetovic M, Song Y, Wolkow N, Iacovelli J, Grieco S, Lee J, Lyubarsky A, Pratico D, Connelly J, Spino M, Harris ZL, Dunaief JL (2011) The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. Invest Ophthalmol Vis Sci. 52(2):959-968.
46. Rogers BS, Symons RC, Komeima K, Shen J, Xiao W, Swaim ME, Gong YY, Kachi S, Campochiaro PA (2007) Differential sensitivity of cones to iron-mediated oxidative damage. Invest Ophthalmol Vis Sci 48:438-445.
47. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22:6578-6586.
48. Dunaief JL, Richa C, Franks EP, Schultze RL, Aleman TS, Schenck JF, Zimmerman EA, Brooks DG (2005) Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 112:1062-1065.
49. Yefimova MG, Jeanny JC, Keller N, Sergeant C, Guillonneau X, Beaumont C, Courtois Y (2002) Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 43:537-545.
50. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134.
51. Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122:598-614.
52. AREDS (2001) A randomized, placebo-controlled, clinical trial of highdose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417-1436.
53. Hahn P, Milam AH, Dunaief JL (2003) Maculas affected by age related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch Ophthalmol 121:1099-1105.
54. Dentchev T, Hahn P, Dunaief JL (2005) Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol 123:1745-1746.
55. Hahn P, Ying GS, Beard J, Dunaief JL (2006) Iron levels in human retina: sex difference and increase with age. Neuroreport 17:1803-1806.
56. Chowers I, Wong R, Dentchev T, Farkas RH, Iacovelli J, Gunatilaka TL, Medeiros NE, Presley JB, Campochiaro PA, Curcio CA, Dunaief JL, Zack DJ (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2135-2140.
57. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539-2543.
58. Pietrangelo A (2006) Hereditary hemochromatosis. Biochim Biophys Acta 1763:700-710.
59. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472-1477.
60. Pietrangelo A (2004) The ferroportin disease. Blood Cells Mol Dis 32:131-138.
61. Pietrangelo A (2005) Non-HFE hemochromatosis. Semin Liver Dis 25:450-460.
62. Nemeth E, Ganz T (2006) Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26:323-342.
63. Roth AM, Foos RY (1972) Ocular pathologic changes in primary hemochromatosis. Arch Ophthalmol 87:507-514.
64. Porter N, Downes SM, Fratter C, Anslow P, Nemeth AH (2007) Catastrophic visual loss in a patient with Friedreich ataxia. Arch Ophthalmol 125:273-274.
65. Koeppen AH, Dickson AC (2001) Iron in the Hallervorden-Spatz syndrome. Pediatr Neurol 25:148-155.
66. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ (2001) A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28:345-349.
67. Newell FW, Johnson RO II, Huttenlocher PR (1979) Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome. Am J Ophthalmol 88:467-471.
68. Luckenbach MW, Green WR, Miller NR, Moser HW, Clark AW, Tennekoon G (1983) Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am J Ophthalmol 95:369-382.
69. Kuo YM, Duncan JL, Westaway SK, Yang H, Nune G, Xu EY, Hayflick SJ, Gitschier J (2005) Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Mol Genet 14:49-57.
70. Cibis PA, Yamashita T, Rodriguez F (1959) Clinical aspects of ocular siderosis and hemosiderosis. AMA Arch Ophthalmol 62:180-187.
71. Talamo JH, Topping TM, Maumenee AE, Green WR (1985) Ultrastructural studies of cornea, iris and lens in a case of siderosis bulbi. Ophthalmology 92:1675-1680.
72. Sneed SR (1988) Ocular siderosis. Arch Ophthalmol 106:997.
73. Knave B (1969) Electroretinography in eyes with retained intraocular metallic foreign bodies. Acta Ophthalmol 100(Suppl):4-63.
74. Declercq SS, Meredith PC, Rosenthal AR (1977) Experimental siderosis in the rabbit: correlation between electroretinography and histopathology. Arch Ophthalmol 95:1051-1058.
75. Gillies A, Lahav M (1983) Absorption of retinal and subretinal hemorrhages. Ann Ophthalmol 15:1068-1074.
76. Glatt H, Machemer R (1982) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94:762-773.
77. Youssef TA, Trese MT, Hartzer M, Mahgoub M, Raza H, Azrak M, Allredge C (2002) Deferoxamine reduced retinal toxicity from subretinal blood. Invest Ophthalmol 43 (E-abstract).
78. Bhisitkul RB, Winn BJ, Lee O, Wong J, de Souza Pereira D, Porco TC, He X, Hahn P, Dunaief JL (2008) Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage. Invest Ophthalmol Vis Sci 49:4071-4077.
79. Ito T, Nakano M, Yamamoto Y, Hiramitsu T, Mizuno Y (1995) Hemoglobin-induced lipid peroxidation in the retina: a possiblemechanism for macular degeneration. Arch Biochem Biophys 316:864-872.
80. Kalinowski DS, Richardson DR (2005) The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev 57:547-583.
81. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS (1986) Lactulose, 51Cr-labelled ethylenediaminetetraacetate, l -rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (London) 71:71-80.
82. Liu ZD, Hider RC (2002) Design of clinically useful iron(III)-selective chelators. Med Res Rev 22:26-64.
83. Lukinova N, Iacovelli J, Dentchev T, Wolkow N, Hunter A, Amado D, Ying GS, Sparrow JR, Dunaief JL (2009) Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. Invest Ophthalmol Vis Sci 50:1440-1447.
84. Kurz T, Karlsson M, Brunk UT, Nilsson SE, Frennesson C (2009) ARPE-19 retinal pigment epithelial cells are highly resistant to oxidative stress and exercise strict control over their lysosomal redox-active iron. Autophagy 5(4):494-501.